Brian Johns

Brian Johns has a strong background in the pharmaceutical industry, with their most recent role being Chief Scientific Officer at Brii Biosciences since January 2024. Prior to that, they held the same position at HemoShear Therapeutics from September 2019 to December 2023. Brian also worked as Vice President at ViiV Healthcare from October 2018 to September 2019. Before that, they had a long tenure at GSK, where they held the positions of VP HIV DPU from August 2016 to September 2018 and Director, HIV Medicinal Chemistry from September 2009 to September 2016.

Brian Johns completed their Bachelor of Science degree in Chemistry at Andrews University from 1989 to 1993. Brian then pursued a post-doctoral program in Organic Chemistry at the University of Virginia from 1997 to 1999. Additionally, there is no information provided regarding their education at Wayne State University from 1993 to 1997.